These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 17499885)
1. Cytotoxic 3,5-bis(benzylidene)piperidin-4-ones and N-acyl analogs displaying selective toxicity for malignant cells. Pati HN; Das U; Quail JW; Kawase M; Sakagami H; Dimmock JR Eur J Med Chem; 2008 Jan; 43(1):1-7. PubMed ID: 17499885 [TBL] [Abstract][Full Text] [Related]
2. Bis[3,5-bis(benzylidene)-4-oxo-1-piperidinyl]amides: a novel class of potent cytotoxins. Das S; Das U; Varela-Ramírez A; Lema C; Aguilera RJ; Balzarini J; De Clercq E; Dimmock SG; Gorecki DK; Dimmock JR ChemMedChem; 2011 Oct; 6(10):1892-9. PubMed ID: 21826795 [TBL] [Abstract][Full Text] [Related]
3. E,E,E-1-(4-Arylamino-4-oxo-2-butenoyl)-3,5-bis(arylidene)-4-piperidones: a topographical study of some novel potent cytotoxins. Jha A; Mukherjee C; Prasad AK; Parmar VS; Clercq ED; Balzarini J; Stables JP; Manavathu EK; Shrivastav A; Sharma RK; Nienaber KH; Zello GA; Dimmock JR Bioorg Med Chem; 2007 Sep; 15(17):5854-65. PubMed ID: 17562365 [TBL] [Abstract][Full Text] [Related]
4. 1-[4-(2-Dimethylaminoethoxy)phenylcarbonyl]-3,5-Bis(3,4,5-Trimethoxybenzylidene)- 4-Piperidone Hydrochloride and Related Compounds: Potent Cytotoxins Demonstrate Greater Toxicity to Neoplasms than Non- Malignant Cells. Roayapalley PK; Dimmock JR; Sakagami H; Okudaira N; Sharma RK; Das U Med Chem; 2022; 18(9):1001-1012. PubMed ID: 35319387 [TBL] [Abstract][Full Text] [Related]
5. Dichloroacetyl Amides of 3,5-Bis(benzylidene)-4-piperidones Displaying Greater Toxicity to Neoplasms than to Non-Malignant Cells. Hossain M; Roayapalley PK; Sakagami H; Satoh K; Bandow K; Das U; Dimmock JR Medicines (Basel); 2022 Jun; 9(6):. PubMed ID: 35736248 [TBL] [Abstract][Full Text] [Related]
6. Cytotoxic N-[4-(3-aryl-3-oxo-1-propenyl)phenylcarbonyl]-3,5-bis(phenylmethylene)-4-piperidones and related compounds. Dimmock JR; Jha A; Zello GA; Quail JW; Oloo EO; Nienaber KH; Kowalczyk ES; Allen TM; Santos CL; De Clercq E; Balzarini J; Manavathu EK; Stables JP Eur J Med Chem; 2002 Dec; 37(12):961-72. PubMed ID: 12660021 [TBL] [Abstract][Full Text] [Related]
7. Tumour-specific cytotoxicity and structure-activity relationships of novel 1-[3-(2-methoxyethylthio)propionyl]-3,5-bis(benzylidene)-4-piperidones. Hossain M; Das U; Umemura N; Sakagami H; Balzarini J; De Clercq E; Kawase M; Dimmock JR Bioorg Med Chem; 2016 May; 24(10):2206-14. PubMed ID: 27073056 [TBL] [Abstract][Full Text] [Related]
8. CoMFA and CoMSIA studies on 1,3-bis(benzylidene)-3,4-dihydro-1H-naphthalen-2-one, 2,6-bis(benzylidene)cyclohexanone, and 3,5-bis(benzylidene)-4-piperidone series of cytotoxic compounds. Patel MR; Dimmock JR; Talele TT J Chem Inf Model; 2007; 47(6):2110-23. PubMed ID: 17944456 [TBL] [Abstract][Full Text] [Related]
9. 3,5-Bis(benzylidene)-1-[4-2-(morpholin-4-yl)ethoxyphenylcarbonyl]-4-piperidone hydrochloride: a lead tumor-specific cytotoxin which induces apoptosis and autophagy. Das U; Sakagami H; Chu Q; Wang Q; Kawase M; Selvakumar P; Sharma RK; Dimmock JR Bioorg Med Chem Lett; 2010 Feb; 20(3):912-7. PubMed ID: 20064715 [TBL] [Abstract][Full Text] [Related]
10. 6-Benzylidene-2-[4-(pyridin-3-ylcarboxy)benzylidene]cyclohexanones: A novel cluster of tumour-selective cytotoxins. Panda AK; Das U; Umemura N; Sakagami H; Kawase M; Balzarini J; De Clercq E; Dimmock SG; Roayapalley PK; Dimmock JR Bioorg Med Chem Lett; 2017 Apr; 27(7):1611-1615. PubMed ID: 28238612 [TBL] [Abstract][Full Text] [Related]
11. E,E-2-Benzylidene-6-(nitrobenzylidene)cyclohexanones: syntheses, cytotoxicity and an examination of some of their electronic, steric, and hydrophobic properties. Das U; Doroudi A; Das S; Bandy B; Balzarini J; De Clercq E; Dimmock JR Bioorg Med Chem; 2008 Jun; 16(11):6261-8. PubMed ID: 18450457 [TBL] [Abstract][Full Text] [Related]
12. 3,5-Bis(benzylidene)-4-oxo-1-phosphonopiperidines and related diethyl esters: Potent cytotoxins with multi-drug-resistance reverting properties. Das S; Das U; Selvakumar P; Sharma RK; Balzarini J; De Clercq E; Molnár J; Serly J; Baráth Z; Schatte G; Bandy B; Gorecki DK; Dimmock JR ChemMedChem; 2009 Nov; 4(11):1831-40. PubMed ID: 19802855 [TBL] [Abstract][Full Text] [Related]
13. The cytotoxic properties and preferential toxicity to tumour cells displayed by some 2,4-bis(benzylidene)-8-methyl-8-azabicyclo[3.2.1] octan-3-ones and 3,5-bis(benzylidene)-1-methyl-4-piperidones. Pati HN; Das U; Das S; Bandy B; De Clercq E; Balzarini J; Kawase M; Sakagami H; Quail JW; Stables JP; Dimmock JR Eur J Med Chem; 2009 Jan; 44(1):54-62. PubMed ID: 18468733 [TBL] [Abstract][Full Text] [Related]
14. Novel hybrid molecules of 3,5-bis(benzylidene)-4-piperidones and dichloroacetic acid which demonstrate potent tumour-selective cytotoxicity. Hossain M; Das S; Das U; Doroudi A; Zhu J; Dimmock JR Bioorg Med Chem Lett; 2020 Feb; 30(3):126878. PubMed ID: 31864797 [TBL] [Abstract][Full Text] [Related]
15. Dimeric 3,5-bis(benzylidene)-4-piperidones: a novel cluster of tumour-selective cytotoxins possessing multidrug-resistant properties. Das S; Das U; Sakagami H; Umemura N; Iwamoto S; Matsuta T; Kawase M; Molnár J; Serly J; Gorecki DK; Dimmock JR Eur J Med Chem; 2012 May; 51():193-9. PubMed ID: 22409967 [TBL] [Abstract][Full Text] [Related]
16. 3,5-Bis(benzylidene)-1-[3-(2-hydroxyethylthio)propanoyl]piperidin-4-ones: a novel cluster of potent tumor-selective cytotoxins. Das U; Pati HN; Sakagami H; Hashimoto K; Kawase M; Balzarini J; De Clercq E; Dimmock JR J Med Chem; 2011 May; 54(9):3445-9. PubMed ID: 21449610 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and cytotoxic properties of novel 1-[4-(2-alkylaminoethoxy)phenylcarbonyl]-3,5-bis(arylidene)-4-piperidones and related compounds. Das U; Alcorn J; Shrivastav A; Sharma RK; De Clercq E; Balzarini J; Dimmock JR Eur J Med Chem; 2007 Jan; 42(1):71-80. PubMed ID: 16996657 [TBL] [Abstract][Full Text] [Related]
18. Dimeric 3,5-Bis(benzylidene)-4-piperidones: Tumor-Selective Cytotoxicity and Structure-Activity Relationships. Das S; Roayapalley PK; Sakagami H; Umemura N; Gorecki DKJ; Hossain M; Kawase M; Das U; Dimmock JR Medicines (Basel); 2024 Jan; 11(1):. PubMed ID: 38248717 [No Abstract] [Full Text] [Related]
19. Design, synthesis and antiproliferative activity of some 3-benzylidene-2,3-dihydro-1-benzopyran-4-ones which display selective toxicity for malignant cells. Perjési P; Das U; De Clercq E; Balzarini J; Kawase M; Sakagami H; Stables JP; Lorand T; Rozmer Z; Dimmock JR Eur J Med Chem; 2008 Apr; 43(4):839-45. PubMed ID: 17692998 [TBL] [Abstract][Full Text] [Related]